Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

NCT00330902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Infections

Interventions

DRUG: sulfadoxine-pyrimethamine (SP) plus artesunate (AS)
DRUG: primaquine (PQ) plus SP+AS

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]
[object Object]